Citius Pharmaceuticals, Inc. (CTXR)
1.18
+0.01
(+0.85%)
USD |
NASDAQ |
Dec 11, 13:12
Citius Pharmaceuticals EPS Diluted (Quarterly): -0.7986 for June 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Citius Oncology, Inc. | -0.075 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.204M |
| Total Expenses (Quarterly) | 8.790M |
| Enterprise Value | 19.91M |
| Earnings Yield | -420.6% |
| Normalized Earnings Yield | -420.63 |